Studies from Transgene SA Provide New Data on Oncolytic Virotherapy (TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment)

Source :: Vaccine Weekly. August 14, 2024, 56
Publication Year :: 2024
Abstract: 2024 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- New study results on oncolytic virotherapy have been published. According to news reporting out of [...]

Subjects :: Transgene S.A. -- Reports
Medical research -- Reports
Medicine, Experimental -- Reports
T cells -- Reports -- Research
Tumors -- Research
Biotechnology industry -- Research -- Reports
Viral antibodies -- Research -- Reports
Vaccinia -- Research
Vaccines -- Research
Interleukins -- Reports -- Research
Antibodies -- Research -- Reports
Health

Tools